Carboplatin Equals Cisplatin: But How Do I Prescribe It?-Reference-Cited by-同舟云学术

Carboplatin Equals Cisplatin: But How Do I Prescribe It?

Published:2003-09-01 Issue:17 Volume:21 Page:3183-3185
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Gore Martin¹

Affiliation:

1. Royal Marsden Hospital, London, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.06.077

Reference37 articles.

1. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

2. Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results

3. McGuire WP, Hoskins WJ, Brady MF, et al: A phase III trial comparing cisplatin/cytoxan (PC) and cisplatin/taxol (PT) in advanced ovarian cancer (AOC): For the Gynecologic Oncology Group (GOG), Buffalo, NY 14263. Proc Am Soc Clin Oncol 12:255,1993, (abstr 808)

4. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.

5. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma;Medical Oncology;2013-07-18

2. Prediction of Progression-Free Survival and Response to Paclitaxel Plus Carboplatin in Patients With Recurrent or Advanced Cervical Cancer;International Journal of Gynecological Cancer;2012-05

3. Effect of Age on Systemic Exposure and Haematological Toxicity of Carboplatin in Advanced Non-Small Cell Lung Cancer Patients;Basic & Clinical Pharmacology & Toxicology;2011-08-08

4. Carboplatin Dosing in Ovarian Cancer;International Journal of Gynecological Cancer;2011-06

5. Factors Affecting the Completion of Intraperitoneal Chemotherapy in Women With Ovarian Cancer;International Journal of Gynecological Cancer;2010-01